| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 14 May 2024 | 23 Feb 2024 |
| We enclose a copy of the Auditors report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with Statement of Assets and Liabilities as on that date and Statement of Cashflows for the year ended 31st December 2023 as required under Regulation 33 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015. Further, the Board has also declared an Interim Dividend of Rs. 50 per equity share and recommended a final dividend of Rs. 117 per equity share. Notice of the Sixty Eighth Annual General Meeting of Sanofi India Limited to be held on May 14, 2024 at 3:30 p.m. (IST) through Video Conferencing/ Other Audio-Visual Means. (As Per BSE Announcement dated on 22.04.2024) Summary of proceedings of the 68th Annual General Meeting of the Company (As per BSE Announcement Dated on 14/05/2024) Summary of proceedings of the 68th Annual General Meeting of the Company (As Per BSE Announcement Dated on 16/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
